When the Drug Quality and Security Act was signed in 2013, it granted the FDA greater authority to regulate and monitor the manufacturing of compounded drugs, and it also created measures to improve drug supply chain safety — a win for pharmacists. On the latest episode of Independent Rx Forum, NCPA’s Ronna Hauser, PharmD, and Lisa Schwartz, PharmD, discuss the implementation of track and trace, an important aspect of DSCSA compliance, whose remaining requirements go into effect on November 27. Independent Rx Forum is a co-production of NCPA and Pharmacy Times.
NCPA
